A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

Clinical trial NCT04773782 · COMPLETED

Trial details

NCT number: NCT04773782
Sponsor: Blueprint Medicines Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Unspecified, Child Relapsed Solid Neoplasm CNS Tumor

Start date: 2022-02-24
Primary completion: 2025-11-21
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.